Biomedical Engineering Reference
In-Depth Information
CRAGG A H, DEJONG S C, BARNHART S K, Nitinol intravascular stent: results of preclinical
evaluation.
Radiology
1993;
189
: 775-778.
CRUZ D, KARLSBERG R, TAKANO Y, VORA D and TOBIS J. Subacute stent thrombosis
associated with a heparin-coated stent and heparin-induced thrombocytopenia.
Cathet Cardiovasc Intervent
2003;
58
: 80-83.
DAEMEN J, WANAWESER P, TSUCHIDA K, ABRECHT L, VAINA S, MORGER C, KUKREJA N, JUNI
P, SIANOS G, HELLIGE G, VAN DOMBERG RT, HESS OM, BOERSMA E, MEIER B, WINDECKER
S and SERRUYS PW. Early and late coronary stent thrombosis of sirolimus and
paclitaxel-eluting stents in routine clinical practice.
Lancet
2007;
369
: 667-678.
DAHL JRV, HAAGER PK, GRUBE E, GROSS M, BEYTHIEN C, KROMER EP
et al.
Effects of gold
coating of coronary stents on neointimal proliferation following stent implanta-
tion.
Am J Cardiol
2002;
89
(7): 801-805.
DANZI G, CAPUANO C, SESNA M, BLASI AD, PREDOLINI S and ANTONIUCCI D. Patterns of
in-stent restenosis after placement of NIR gold-coated stents in unselected
patients.
Catheter Cardiovasc Interv
2002;
55
(2): 157-162.
DICHEK DA, NEVILLE RF, ZWIEBEL JA, FREEMAN SM, LEON MB and ANDERSON WF. Seeding
of intravascular stents with genetically engineered endothelial cells.
Circulation
1989;
80
: 1347-1353.
DI MARIO C, GRUBE E, NISANCI Y, REIFART N, COLOMBO A, RODERMANN J, MULLER R, UMMAN
S, LIISTRO F, MONTORFANO M and ALT E. MOONLIGHT: a controlled registry of an
iridium oxide-coated stent with angiographic follow-up.
Int J Cardiol
2004;
95
:
329-331.
DONACHIE M. Biomedical alloys.
Adv Mater Proc
1998;
7
: 63-65.
EDELMAN ER, SEIFERT P, GROOTHUIS A, MORSS A, BORNSTEIN D and ROGERS C. Gold-
coated NIR stents in porcine coronary arteries.
Circulation
2001;
103
: 429-434.
FI SCHELL TA, KHARMA BK, FI SCHELL DR
et al.
Low-dose beta-particle emission from
'stent' wire results in complete, localized inhibition of smooth muscle cell prolif-
eration.
Circulation
1994;
90
: 2956-2963.
FI SCHELL TA, DISHMON D, ELHADDI A, ALSAFWAH S and MANNEM SR. The perfect drug-
eluting stent.
Cardiac Interv Today
2009;
June/July
: 29-36.
FL ESSER A and LECLERC G. The current status of stenting: pathobiology.
Trends Car-
diovasc Med
1997;
5
: 24-28.
FOTI, R, TAMBURINO C, GALASSI AR, RUSSO G, NICOSIA A, GRASSI R, MONACO A, AZZARELLI
S, MAMMANA C, CALVI V and GIUFFRIDA G. Safety, feasibility and effi cacy of a new
single-wire stent in the treatment of complex coronary lesions: the angiostent.
Cardiologia
1998;
43
(7): 725-730.
FRAGA C G and OTEIZA P I. Iron toxicity and antioxidant nutrients.
Toxicology
2002;
180
: 23-32.
GANDHI MM and DAWKINS KD. Intracoronary stents: clinical review.
Br Med J
1999;
318
: 650-652.
GOTMANN I. Characteristics of metals used in implants.
J Endourol
1997;
11
:
383-389.
GRENADIER E, ROGUIN A, HERTZ I, PELED B, BOULOS M, NIKOLSKY E, AMIKAM S, KERNER
A, COHEN S and BEYAR R. Stenting very small coronary narrowings (
2 mm) using
the biocompatible phosphorylcholine-coated coronary stent.
Catheter Cardiovasc
Interv
2002;
55
(3): 303-308.
GUILDFORD AL, COLOMBO P, BRUSCHI G, BONACINA E, KLUGMANN S and SANTIN M. Direct
comparison of the short-term clinical performance of Z Guidant and Taxus stents.
Int J Cardiol
2009; doi: 10.1016/j.ijcard.2008.12.161.
<
Search WWH ::
Custom Search